Table 1.
Clinical and microbiologic data of Ochrobactrum anthropi isolates resistant to carbapenems
| Isolate | Age/sex | Unit | Diagnosis | IMP MIC (μg/mL) | MEM MIC (μg/mL) | Rapid Blue-Carba test | MEM-DA | bla PCR reactionsa |
|---|---|---|---|---|---|---|---|---|
| 1 | 2 months/F | Paediatrics | Suspected sepsis | 8 | >16 | + | + | — |
| 2 | 2 years/F | Paediatrics | Pneumonia | 8 | >16 | + | + | — |
| 3 | 6 years/F | Paediatrics | Pneumonia | 4 | >16 | + | + | — |
| 4 | 59 years/M | Trauma | Chronic osteomyelitis | 8 | >16 | + | + | — |
| 5 | 18 years/F | Maternity | Puerperal fever | 8 | >16 | + | + | — |
| 6 | 6 months/F | Paediatrics | Pneumonia | 8 | >16 | + | + | — |
| BCT isolate | NA | NA | NA | 8 | >16 | + | + | — |
| Unrelated strain | NA | NA | NA | 0.06 | 0.25 | — | — | — |
BCT, blood culture tube; MEM-DA, meropenem and dipicolinic acid synergy test; NA, not applicable.
a
bla PCR reactions: IMP, VIM, KPC, NDM-1.